Delivery Order SPE2DB22D2206-SPE2DB24FFJ82
Award Date 1/31/24
Potential Completion Date 2/22/24
Potential Value $4.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,756.72 firm-fixed-price delivery order is for the supply of 4565111059 HYPERRAB 300 UNIT/ML VIAL 5ML pharmaceutical products. This award is part of a larger single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,411.16 firm fixed-price delivery order is for HYPERRAB 300 UNIT/ML VIAL 3ML, with an ultimate completion date of June 12, 2025. The contract is not set aside for any particular business size or type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,263.36 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL Vials on January 14, 2026, with an ultimate completion date of February 5, 2026. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to the Place of Performance in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract worth $3,373.68 by the Defense Logistics Agency (DLA) to provide HYPERRAB 300 UNIT/ML VIAL 3ML pharmaceuticals. The contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designations. The company also holds an Indefinite Delivery Contract with DLA worth up to...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $4,348.80 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide 4562224597 units of HYPERRAB 300 UNIT/ML vials. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 19, 2023 through October 11, 2023. No subcontractors or set aside designations...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,067.31 Firm Fixed Price Delivery Order contract is for the provision of HYPERRAB 300UNIT/ML 1S medical supplies. The contract has an ultimate completion date of July 14, 2025 and was awarded on June 13, 2025 without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,609.00, is for the delivery of HYPERRAB 300UNIT/ML 1S medical supplies. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,721.90 firm fixed-price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIALML, a medical product, with a period of performance through November 12, 2024. The contract is an indefinite delivery vehicle and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,760.40 firm fixed price delivery order is for HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of November 30, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, particularly the...
- The Defense Logistics Agency awarded a $17,908 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of HYPERRAB 300 Unit/ML vial in 5ML quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...